U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Drug Development Tool Qualification Programs
  5. CDER Biomarker Qualification Program
  6. Resources for Biomarker Requestors
  1. CDER Biomarker Qualification Program

Resources for Biomarker Requestors

Get Started With Your Submission

How to engage with the Biomarker Qualification Program (BQP)

If you have questions please contact BQP at: CDER-BiomarkerQualificationProgram@fda.hhs.gov

Biomarker qualification is a process involving three stages that provide increasing levels of detail for the development of a biomarker for its proposed context of use (COU). Here we provide resources to assist requestors in making complete submissions to the CDER Biomarker Qualification Program.

Qualification Process

See 21st Century Cures Act: Qualification of DDT for a description of how the process for qualification of drug development tools is changing under new FD&C Act Section 507.

Qualification Stages & Submissions

Biomarker Qualification Submitting Procedures

All Biomarker Qualification submissions must be transferred to an optical disc storage media format (i.e., CD or DVD) containing the submission and digital Cover Letter accompanied by a paper copy of the Cover Letter.

Email Alert for Correspondence and Submissions 

Please notify us via email CDER-BiomarkerQualificationProgram@fda.hhs.gov once sending a submission.

Submission Mailing Address

The paper copy Cover Letter and electronic media should be mailed to:
CDER Central Document Room
ATTN: Biomarker Qualification Program
5901-B Ammendale Road,
Beltsville, MD 20705-1266.

Important Information for Requestors